Cardiac device innovations made waves in 2024, with regulatory approvals, clinical breakthroughs, and product launches ...
J&J issued a press release on January 8, 2025, announcing that "on January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback